PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
47.06%
Positive growth while VET shows revenue decline. John Neff would investigate competitive advantages.
10.44%
Cost increase while VET reduces costs. John Neff would investigate competitive disadvantage.
89.19%
Positive growth while VET shows decline. John Neff would investigate competitive advantages.
28.65%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.44%
Other expenses reduction while VET shows 354.44% growth. Joel Greenblatt would examine efficiency.
-15.24%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
3.41%
Total costs growth while VET reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
-0.24%
Both companies reducing D&A. Martin Whitman would check industry patterns.
107.69%
EBITDA growth while VET declines. John Neff would investigate advantages.
42.38%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
170.91%
Operating income growth while VET declines. John Neff would investigate advantages.
84.22%
Operating margin growth while VET declines. John Neff would investigate advantages.
-40.00%
Other expenses reduction while VET shows 248.09% growth. Joel Greenblatt would examine advantage.
177.77%
Pre-tax income growth while VET declines. John Neff would investigate advantages.
88.89%
Pre-tax margin growth exceeding 1.5x VET's 4.35%. David Dodd would verify competitive advantages.
150.51%
Tax expense growth while VET reduces burden. John Neff would investigate differences.
190.99%
Net income growth while VET declines. John Neff would investigate advantages.
97.88%
Net margin growth exceeding 1.5x VET's 18.11%. David Dodd would verify competitive advantages.
190.80%
EPS growth while VET declines. John Neff would investigate advantages.
190.18%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
0.01%
Share count reduction exceeding 1.5x VET's 0.17%. David Dodd would verify capital allocation.
No Data
No Data available this quarter, please select a different quarter.